Delivery Order SPE2DB20D1004-SPE2DB23FF3Y6

Award Date 3/8/23
Potential Completion Date 3/9/23
Potential Value $2.1K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,304.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of esomeprazole magnesium delayed-release 20 mg capsules in quantities of 1,000. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,152.91 fixed-price delivery order is for the supply of Esomeprazole Magnesium delayed-release capsules, a proton pump inhibitor medication. The award is part of a broader Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Esomeprazole Magnesium Delayed-Release capsules. The $1,506.76 firm fixed-price delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major supplier of medical commodities to the U.S. Department of Defense and other federal agencies. The contract, valued at $1,545.84, was awarded to Amerisourcebergen Drug Corporation, a large pharmaceutical distributor, to provide 4565232169 - Esomeprazole Magnesium Delayed Release 40 mg Capsules in 30-count packages. The contract is a Delivery Order with a Firm Fixed Price pricing type and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,763,689 units of Esomeprazole Magnesium Delayed Release 40 mg capsules. The delivery order, valued at $2,823.89, is a firm-fixed price contract with a completion date of September 12, 2024. This award is not associated with any set-aside program. Amerisourcebergen, through its Corporate Office division, has been a significant...
This federal contract award, valued at $3,488.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Esomeprazole Magnesium Delayed Release 40 mg capsules, a cardiovascular medication. The award is structured as a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Esomeprazole Magnesium Delayed-Release 40 mg capsules to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,332.60 and is a firm fixed-price delivery order with an ultimate completion date of December 2, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract award is not designated as a set-aside. Amerisourcebergen holds a...
This federal contract award is for the delivery of esomeprazole magnesium delayed-release capsules, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $4,836.21 and is a delivery order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,086.09 firm fixed price delivery order is for the supply of Esomeprazole Magnesium Delayed-Release capsules, a medication used for treating certain gastrointestinal conditions. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award, valued at $6,459.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of esomeprazole magnesium delayed-release capsules, a medication used to treat conditions like gastroesophageal reflux disease. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 11, 2023. The contract is not designated with a set-aside requirement,...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF3Y6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,065.31 firm fixed-price delivery order covers the supply of Esomeprazole Magnesium Delayed Release 20 mg Capsules.

The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract award did not have a set-aside designation, indicating it was competed on an unrestricted basis. Amerisourcebergen, as the prime contractor, has the capabilities to fulfill a wide variety of medical commodity requirements for the DLA, which oversees procurement for the Department of Defense's military treatment facilities and other federal healthcare programs.

Generated 2/27/25, 1:36 PM